These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17678471)

  • 1. Short communication: decreasing soluble CD30 and increasing IFN-gamma plasma levels are indicators of effective highly active antiretroviral therapy.
    Sadeghi M; Süsal C; Daniel V; Naujokat C; Zimmermann R; Huth-Kühne A; Opelz G
    AIDS Res Hum Retroviruses; 2007 Jul; 23(7):886-90. PubMed ID: 17678471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMMUNOLOGICAL PROFILES IN HIV POSITIVE PATIENTS FOLLOWING HAART INITIATION IN KIGALI, RWANDA.
    Twizerimana AP; Mwatha J; Musabyimana JP; Kayigi E; Harelimana Jde D; Karanja SM; Mutesa L
    East Afr Med J; 2014 Aug; 91(8):261-6. PubMed ID: 26862650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
    Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
    AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
    Sindhu S; Toma E; Cordeiro P; Ahmad R; Morisset R; Menezes J
    J Med Virol; 2006 Apr; 78(4):431-9. PubMed ID: 16482539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant link between sCD30 changes and HIV viremia in patients treated with HAART.
    Biswas P; Cozzi-Lepri A; Delfanti F; Galli A; Colangeli V; Moioli MC; Scarchilli A; Abrescia N; Vigevani G; D'Arminio-Monforte A; Novati R; Lazzarin A
    J Med Virol; 2006 Dec; 78(12):1513-9. PubMed ID: 17063513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy.
    Keane NM; Price P; Lee S; Stone SF; French MA
    Clin Exp Immunol; 2001 Oct; 126(1):111-6. PubMed ID: 11678906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective IL-2 production by HIV-1-specific CD4 and CD8 T cells in an adolescent/young adult cohort.
    Kapogiannis BG; Henderson SL; Nigam P; Sharma S; Chennareddi L; Herndon JG; Robinson HL; Amara RR
    AIDS Res Hum Retroviruses; 2006 Mar; 22(3):272-82. PubMed ID: 16545014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TH1/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion.
    Solgi G; Amirzagar AA; Pourmand G; Mehrsai AR; Taherimahmoudi M; Baradaran N; Nicknam MH; Ebrahimi Rad MR; Saraji A; Asadpoor AA; Moheiydin M; Nikbin B
    Transplant Proc; 2009 Sep; 41(7):2800-4. PubMed ID: 19765439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of soluble CD30 after allogeneic stimulation is mediated by memory T cells and regulated by IFN-γ and IL-2.
    Velásquez SY; García LF; Opelz G; Alvarez CM; Süsal C
    Transplantation; 2013 Jul; 96(2):154-61. PubMed ID: 23857000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic changes of Th1/Th2/Th17 cytokines and human beta defensin 2 in HIV-infected patients with oral candidiasis during the first year of highly active anti-retroviral therapy.
    Yong X; Liu Z; Jiang L; Tao R; Liu W; Zhang L; Peng Y; Lin X; Huang Y
    Arch Oral Biol; 2018 Aug; 92():62-67. PubMed ID: 29753928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapy.
    Ostrowski SR; Katzenstein TL; Pedersen M; Høyer-Hansen G; Gerstoft J; Pedersen BK; Ullum H
    Scand J Immunol; 2006 Jun; 63(6):478-86. PubMed ID: 16764702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients.
    Brazille P; Dereuddre-Bosquet N; Leport C; Clayette P; Boyer O; Vildé JL; Dormont D; Benveniste O
    Clin Exp Immunol; 2003 Feb; 131(2):304-11. PubMed ID: 12562393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases.
    Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):329-35. PubMed ID: 11242519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent HIV-1 replication does not explain low levels of T-cell interferon-gamma mRNA and elevated serum NO(2) (-)/NO(3) (-) in patients with stable CD4 T-cell responses to HAART.
    Lee S; Almeida CA; French MA; Price P
    Clin Exp Immunol; 2004 Oct; 138(1):110-5. PubMed ID: 15373912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naive CD4+ T lymphocytes express high levels of Bcl-2 after highly active antiretroviral therapy for HIV infection.
    Airò P; Torti C; Uccelli MC; Malacarne F; Palvarini L; Carosi G; Castelli F
    AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1805-7. PubMed ID: 11118066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapy.
    Imami N; Antonopoulos C; Hardy GA; Gazzard B; Gotch FM
    AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1499-508. PubMed ID: 10580400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients.
    Bourgarit A; Carcelain G; Martinez V; Lascoux C; Delcey V; Gicquel B; Vicaut E; Lagrange PH; Sereni D; Autran B
    AIDS; 2006 Jan; 20(2):F1-7. PubMed ID: 16511406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART.
    Stone SF; Price P; Keane NM; Murray RJ; French MA
    HIV Med; 2002 Jan; 3(1):21-7. PubMed ID: 12059947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased bone marrow (BM) plasma level of soluble CD30 and correlations with BM plasma level of interferon (IFN)-γ, CD4/CD8 T-cell ratio and disease severity in aplastic anemia.
    Wu Q; Zhang J; Shi J; Ge M; Li X; Shao Y; Yao J; Zheng Y
    PLoS One; 2014; 9(11):e110787. PubMed ID: 25383872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.